FORTIS MALAR HOSPITALS LIMITED Financials Fortis Malar Hospitals Limited
Equities
FORTISMLR6
INE842B01015
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.46 INR | -2.00% |
|
-9.58% | +31.62% |
| 04-12 | Fortis Malar Hospitals Limited Approves Declaration of Interim Dividend | CI |
| 03-29 | Fortis Malar Hospitals Board to Conisder Interim Dividend for Fiscal 2024 | MT |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,084 | 1,035 | 805.9 | 1,039 | 1,080 | 893.6 |
| Enterprise Value (EV) 1 | 939.1 | 970.8 | 1,019 | 1,477 | 1,490 | 1,264 |
| P/E ratio | 32.8 x | 50.5 x | -9.05 x | -13.2 x | -13.1 x | -5.77 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.73 x | 0.72 x | 0.72 x | 1.5 x | 1.25 x | 1.04 x |
| EV / Revenue | 0.63 x | 0.67 x | 0.91 x | 2.13 x | 1.73 x | 1.47 x |
| EV / EBITDA | 85.5 x | -32.8 x | -8.53 x | -9.21 x | -26 x | -32.5 x |
| EV / FCF | 23.3 x | -9.39 x | 1.49 x | -3.56 x | 10.1 x | -3.38 x |
| FCF Yield | 4.29% | -10.6% | 67.1% | -28.1% | 9.87% | -29.6% |
| Price to Book | 1.05 x | 0.98 x | 0.84 x | 1.17 x | 1.35 x | 1.39 x |
| Nbr of stocks (in thousands) | 18,664 | 18,821 | 18,742 | 18,742 | 18,742 | 18,742 |
| Reference price 2 | 58.10 | 55.00 | 43.00 | 55.45 | 57.65 | 47.68 |
| Announcement Date | 9/4/18 | 9/7/19 | 8/5/20 | 7/6/21 | 7/1/22 | 7/7/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,492 | 1,446 | 1,119 | 692.4 | 861.8 | 859.5 |
| EBITDA 1 | 10.98 | -29.58 | -119.4 | -160.3 | -57.25 | -38.94 |
| EBIT 1 | -24.66 | -67.35 | -152.3 | -192.1 | -90.94 | -73.06 |
| Operating Margin | -1.65% | -4.66% | -13.61% | -27.75% | -10.55% | -8.5% |
| Earnings before Tax (EBT) 1 | 55.91 | 27.91 | -119.4 | -113.1 | -82.61 | -70.08 |
| Net income 1 | 33.22 | 20.56 | -88.94 | -78.69 | -82.74 | -154.8 |
| Net margin | 2.23% | 1.42% | -7.95% | -11.36% | -9.6% | -18.01% |
| EPS 2 | 1.770 | 1.090 | -4.750 | -4.200 | -4.414 | -8.260 |
| Free Cash Flow 1 | 40.24 | -103.4 | 683.4 | -414.8 | 147.2 | -374 |
| FCF margin | 2.7% | -7.15% | 61.09% | -59.91% | 17.08% | -43.51% |
| FCF Conversion (EBITDA) | 366.48% | - | - | - | - | - |
| FCF Conversion (Net income) | 121.15% | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/4/18 | 9/7/19 | 8/5/20 | 7/6/21 | 7/1/22 | 7/7/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 213 | 437 | 410 | 370 |
| Net Cash position 1 | 145 | 64.4 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -1.782 x | -2.729 x | -7.162 x | -9.507 x |
| Free Cash Flow 1 | 40.2 | -103 | 683 | -415 | 147 | -374 |
| ROE (net income / shareholders' equity) | 3.28% | 1.97% | -8.81% | -8.5% | -9.8% | -21.5% |
| ROA (Net income/ Total Assets) | -1.1% | -2.81% | -5.53% | -6.62% | -3.44% | -3.06% |
| Assets 1 | -3,015 | -732.3 | 1,609 | 1,188 | 2,402 | 5,067 |
| Book Value Per Share 2 | 55.20 | 56.20 | 51.40 | 47.40 | 42.80 | 34.20 |
| Cash Flow per Share 2 | 7.770 | 2.690 | 23.00 | 3.960 | 6.620 | 3.130 |
| Capex 1 | 35.2 | 27.1 | 33.1 | 5.29 | 14 | 18.8 |
| Capex / Sales | 2.36% | 1.87% | 2.96% | 0.76% | 1.63% | 2.18% |
| Announcement Date | 9/4/18 | 9/7/19 | 8/5/20 | 7/6/21 | 7/1/22 | 7/7/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +31.62% | 17.73M | |
| +17.18% | 85.55B | |
| -28.48% | 70.07B | |
| +6.76% | 28.95B | |
| -7.44% | 17.51B | |
| +2.14% | 17.39B | |
| +2.10% | 15.38B | |
| +7.02% | 13.4B | |
| +64.96% | 12.93B | |
| +6.64% | 12.77B |
- Stock Market
- Equities
- FORTISMLR6 Stock
- Financials Fortis Malar Hospitals Limited